Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Cote

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Thyroid : Official Journal of the American Thyroid Association|February 18, 2021
Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid CarcinomaYu Qin, Jennifer R Wang, Ying Wang, et al.
Thyroid : Official Journal of the American Thyroid Association|January 11, 2017
Patterns of Treatment Failure in Anaplastic Thyroid CarcinomaSarika N Rao, Mark Zafereo, Ramona Dadu, et al.
Thyroid : Official Journal of the American Thyroid Association|September 28, 2016
Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationJian Yu Xu, Elizabeth G Grubbs, Steven G Waguespack, et al.
Thyroid : Official Journal of the American Thyroid Association|January 19, 2019
Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African AncestryZachary Hurst, Sandya Liyanarachchi, Huiling He, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid CarcinomaGilbert J Cote, Caitlin Evers, Mimi I Hu, et al.
JCO Precision Oncology|February 9, 2022
Circulating <i>BRAF</i> V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Gilbert J Cote, Tao Hai, et al.
Surgery|November 6, 2018
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accidentSarah B Fisher, Gilbert J Cote, Jacquelin H Bui-Griffith, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2014
RET fusion as a novel driver of medullary thyroid carcinomaElizabeth G Grubbs, Patrick Kwok-Shing Ng, Jacquelin Bui, et al.
Annals of Surgical Oncology|February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or ParagangliomaMinerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Thyroid : Official Journal of the American Thyroid Association|February 18, 2021
Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid CarcinomaYu Qin, Jennifer R Wang, Ying Wang, et al.
Thyroid : Official Journal of the American Thyroid Association|January 11, 2017
Patterns of Treatment Failure in Anaplastic Thyroid CarcinomaSarika N Rao, Mark Zafereo, Ramona Dadu, et al.
Thyroid : Official Journal of the American Thyroid Association|September 28, 2016
Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationJian Yu Xu, Elizabeth G Grubbs, Steven G Waguespack, et al.
Thyroid : Official Journal of the American Thyroid Association|January 19, 2019
Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African AncestryZachary Hurst, Sandya Liyanarachchi, Huiling He, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid CarcinomaGilbert J Cote, Caitlin Evers, Mimi I Hu, et al.
JCO Precision Oncology|February 9, 2022
Circulating <i>BRAF</i> V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Gilbert J Cote, Tao Hai, et al.
Surgery|November 6, 2018
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accidentSarah B Fisher, Gilbert J Cote, Jacquelin H Bui-Griffith, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2014
RET fusion as a novel driver of medullary thyroid carcinomaElizabeth G Grubbs, Patrick Kwok-Shing Ng, Jacquelin Bui, et al.
Annals of Surgical Oncology|February 11, 2018
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or ParagangliomaMinerva A Romero Arenas, Thereasa A Rich, Samuel M Hyde, et al.
Pageof 7